SCTX on Nasdaq

Scribe Therapeutics, Inc.

American biological products company, incorporated in Delaware. Summary from the record

Price unavailable

Last updated Oct 19, 2026.

Overview

Compare with another stock.

  • TickerSCTX on Nasdaq1
  • IndustryBiological Products, (No Diagnostic Substances)1
  • HeadquartersAlameda, California1
  • Incorporated inDE2
  • Business address1150 Marina Village Pkwy, Alameda, Ca 945012
  • Filer categoryNon-accelerated filer, Smaller reporting company, Emerging growth company2

See how the biggest companies compare on our leaderboards

Leadership

Who has led Scribe Therapeutics, Inc., and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. Benjamin L. Oakes2026–now

President

  1. Benjamin L. Oakes2026–now

Chief financial officer

  1. David Parrot2026–now
Board members and other officers (5)

Timeline

  1. Jul 23, 2026New chief executive Benjamin L. Oakes becomes CEO3

Filings

45 filings to the SEC since October 2021: 1 quarterly reports, 2 major events, 25 insider forms, 4 large holders, 13 other. The latest 20:

  1. Sep 2, 202610-Q EDGAR
  2. Sep 2, 20268-K EDGAR
  3. Aug 3, 2026SCHEDULE 13G EDGAR
  4. Jul 30, 2026SCHEDULE 13D EDGAR
  5. Jul 30, 2026SCHEDULE 13D EDGAR
  6. Jul 29, 20264 EDGAR
  7. Jul 29, 20264 EDGAR
  8. Jul 29, 20264 EDGAR
  9. Jul 29, 20264 EDGAR
  10. Jul 29, 2026SCHEDULE 13D EDGAR
  11. Jul 28, 20264 EDGAR
  12. Jul 28, 20264 EDGAR
  13. Jul 27, 20264 EDGAR
  14. Jul 27, 20264 EDGAR
  15. Jul 27, 20264 EDGAR
  16. Jul 27, 20264 EDGAR
  17. Jul 27, 20264 EDGAR
  18. Jul 27, 20264 EDGAR
  19. Jul 27, 20268-K EDGAR
  20. Jul 27, 2026S-8 EDGAR

The 45 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

7 open-market trades by officers, directors and large owners since October 2021: 7 buys and 0 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
Jul 28, 2026Avoro Ventures LLCDirectorBuy7,905$18.25$144.3KForm 4
Jul 27, 2026AH Equity Partners Bio II, L.L.C.10% ownerBuy333,333$15.00$5.0MForm 4
Jul 27, 2026GORDON CARL LDirectorBuy1,000,000$15.00$15.0MForm 4
Jul 27, 2026ORBIMED ADVISORS LLCDirectorBuy1,000,000$15.00$15.0MForm 4
Jul 24, 2026Avoro Ventures LLCDirectorBuy2,383,333$15.15$36.1MForm 4
Jul 23, 2026Parrot DavidChief Financial OfficerBuy2,666$15.00$40.0KForm 4
Jul 23, 2026Lucas SvetlanaChief Business OfficerBuy3,000$15.00$45.0KForm 4

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12